SECOND SIGHT MED PRODS INC - COM (EYES) Institutional Ownership

CUSIP: 81362J100

13F Institutional Holders and Ownership History from Q4 2014 to Q4 2020

Type / Class
Equity / COM
Symbol
EYES
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 81362J100?
CUSIP 81362J100 identifies EYES - SECOND SIGHT MED PRODS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM (EYES) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q4 0 $0 -$484,000 0
2020 Q3 561,612 $484,000 $0.86 1
2020 Q2 561,612 $550,211 -$23,000 $0.98 1
2020 Q1 561,612 $558,635 -$5,730,517 $0.99 1
2019 Q4 6,975,020 $5,179,034 -$232,450 $0.74 19
2019 Q3 7,261,116 $5,982,271 -$58,698 $0.82 34
2019 Q2 7,335,287 $5,871,989 -$422,768 $0.80 38
2019 Q1 7,870,760 $6,259,930 +$391,785 $0.80 40
2018 Q4 7,363,670 $6,518,539 -$109,781 $0.89 37
2018 Q3 7,347,088 $13,960,674 +$170,138 $1.90 41
2018 Q2 7,230,792 $12,004,062 +$154,327 $1.66 37
2018 Q1 7,125,324 $13,681,533 -$1,011,650 $1.92 38
2017 Q4 7,655,435 $14,623,603 +$1,144,784 $1.91 43
2017 Q3 7,203,066 $8,641,583 -$244,473 $1.20 40
2017 Q2 7,418,425 $9,303,233 -$1,683,644 $1.26 40
2017 Q1 8,776,186 $10,616,351 +$7,402,934 $1.21 53
2016 Q4 3,486,472 $6,864,140 +$1,033,561 $1.97 57
2016 Q3 2,764,591 $9,716,215 -$316,585 $3.52 48
2016 Q2 2,844,990 $10,179,275 -$121,094 $3.58 53
2016 Q1 2,690,772 $12,994,739 -$2,907,625 $4.83 51
2015 Q4 3,369,977 $19,846,444 +$6,663,031 $5.89 58
2015 Q3 2,237,991 $13,270,989 +$2,635,462 $5.93 48
2015 Q2 1,772,864 $24,130,668 +$6,762,232 $13.61 49
2015 Q1 448,326 $5,744,859 -$7,019,373 $12.81 24
2014 Q4 1,297,647 $13,313,901 +$10,659,901 $10.26 39